Keenan J, Oliaro J, Domigan N, Potter H, Aitken G, Allardyce R, Roake J
Departments of Surgery, Christchurch School of Medicine, Christchurch, Animal and Biomedical Sciences, Massey University, Palmerston North, New Zealand.
Infect Immun. 2000 Jun;68(6):3337-43. doi: 10.1128/IAI.68.6.3337-3343.2000.
Experiments were performed using the standardized murine model of Helicobacter pylori infection to determine the immunogenicity of H. pylori outer membrane vesicles in immune protection. These vesicles, which are naturally shed from the surface of the bacterium, induce a protective response when administered intragastrically to mice in the presence of cholera holotoxin, despite the absence of the urease enzyme and associated Hsp54 chaperonin. Immunoblotting identified a specific serum immunoglobulin G (IgG) response to an 18-kDa outer membrane protein in a significant number of immunized animals. This commonly expressed, immunodominant protein was subsequently identified as lipoprotein 20 (Lpp20). Hybridoma backpacks secreting an IgG1 subclass monoclonal antibody to Lpp20 were generated in H. pylori-infected mice and were found to significantly reduce bacterial numbers, providing evidence that this surface-exposed antigen is a true vaccine candidate and not merely an antigenic marker for successful, protective immunization.
使用幽门螺杆菌感染的标准化小鼠模型进行实验,以确定幽门螺杆菌外膜囊泡在免疫保护中的免疫原性。这些囊泡是从细菌表面自然脱落的,在存在霍乱全毒素的情况下经胃内给药给小鼠时,尽管缺乏脲酶和相关的Hsp54伴侣蛋白,仍能诱导保护性反应。免疫印迹法在大量免疫动物中鉴定出针对一种18 kDa外膜蛋白的特异性血清免疫球蛋白G(IgG)反应。这种普遍表达的免疫显性蛋白随后被鉴定为脂蛋白20(Lpp20)。在幽门螺杆菌感染的小鼠中产生了分泌针对Lpp20的IgG1亚类单克隆抗体的杂交瘤细胞株,发现其能显著减少细菌数量,这表明这种表面暴露抗原是一种真正的疫苗候选物,而不仅仅是成功的保护性免疫的抗原标志物。